Modulation of antigen-induced chronic fatigue in mouse model of water immersion stress by naringin, a polyphenolic antioxidant

Fundamental and Clinical Pharmacology

Volumn 23, Issue 3, 2009, Pages 331-337

  Vij, Garima ^a   Gupta, Amit ^a   Chopra, Kanwaljit ^a  

^a PANJAB UNIVERSITY   (India)

Author keywords

Chronic fatigue syndrome; hyperalgesia; immobility time; immunogen; naringin; oxidative stress; tumor necrosis factor alpha

Indexed keywords

AURANTIIN; BACTERIAL ANTIGEN; LIPOPOLYSACCHARIDE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIOXIDANT ACTIVITY; ARTICLE; BRUCELLA ABORTUS; CHRONIC FATIGUE SYNDROME; DIET SUPPLEMENTATION; DISEASE MODEL; DOSE RESPONSE; DRUG DOSE COMPARISON; HYPERALGESIA; IMMOBILIZATION; IMMUNOMODULATION; LATENT PERIOD; MOUSE; NONHUMAN; OXIDATIVE STRESS; PHYSICAL STRESS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROVOCATION TEST; WATER IMMERSION;

ANIMALS; ANTIGENS, BACTERIAL; ANTIOXIDANTS; BRUCELLA ABORTUS; DISEASE MODELS, ANIMAL; FATIGUE SYNDROME, CHRONIC; FLAVANONES; LIPOPOLYSACCHARIDES; MICE; OXIDATIVE STRESS; SWIMMING; TUMOR NECROSIS FACTOR-ALPHA;

EID: 67049174156     PISSN: 07673981     EISSN: 14728206     Source Type: Journal    
DOI: 10.1111/j.1472-8206.2009.00675.x     Document Type: Article

References (55)

1. Fukuda K., Straus S.E., Hickie I., Sharpe M.C., Dobbins J.G., Komaroff A. The chronic fatigue syndrome: a comprehensive approach to its definition and study. International Chronic Fatigue Syndrome Study Group. Ann. Intern. Med. (1994) 121 953 959.
2. Reeves W.C., Wagner D., Nisenbaum R. et al. Chronic fatigue syndrome - a clinically empirical approach to its definition and study. BMC Med. (2005) 3 19.
3. Wyller V.B. The chronic fatigue syndrome - an update. Acta Neurol. Scand. Suppl. (2007) 187 7 14. (Pubitemid 46535909)
4. Chao C.C., DeLaHunt M., Hu S., Close K., Peterson P.K. Immunologically mediated fatigue: a murine model. Clin. Immunol. Immunopathol. (1992) 64 161 165.
5. Klimas N.G., Koneru A.O. Chronic fatigue syndrome: inflammation, immune function and neuroendocrine interactions. Curr. Rheumatol. Rep. (2007) 9 482 487. (Pubitemid 350305206)
6. Wu X.Y., Han S.P., Ren M.Y., Chang Y., Yu F.X. The role of NF-kappaB activation in lipopolysaccharide induced keratitis in rats. Chin. Med. J. (Engl). (2005) 118 1893 1899. (Pubitemid 41748749)
7. Zacharowski K., Frank S., Otto M. et al. Lipoteichoic acid induces delayed protection in the rat heart: a comparison with endotoxin. Arterioscler. Thromb. Vasc. Biol. (2000) 20 1521 1528. (Pubitemid 30353883)
8. Pall M.L. Elevated, sustained peroxynitrite levels as the cause of chronic fatigue syndrome. Med. Hypotheses. (2000) 54 115 125. (Pubitemid 30156647)
9. Pall M.L., Satterlee J.D. Elevated nitric oxide/peroxynitrite mechanism for the common etiology of multiple chemical sensitivity, chronic fatigue syndrome, and posttraumatic stress disorder. Ann. N Y Acad. Sci. (2001) 933 323 329. (Pubitemid 32386045)
10. Ottenweller J.E., Natelson B.H., Gause W.C. et al. Mouse running activity is lowered by Brucella abortus treatment: a potential model to study chronic fatigue. Physiol. Behav. (1998) 63 795 801. (Pubitemid 28270538)
11. Svetic A., Jian Y.C., Lu P., Finkelman F.D., Gause W.C. Brucella abortus induces a novel cytokine gene expression pattern characterized by elevated IL-10 and IFN-gamma in CD4 + T cells. Int. Immunol. (1993) 5 877 883. (Pubitemid 23241759)
12. Sugino K., Dohi K., Yamada K., Kawasaki T. The role of lipid peroxidation in endotoxin-induced hepatic damage and the protective effect of antioxidants. Surgery (1987) 101 746 752. (Pubitemid 17103576)
13. Sakaguchi S., Furusawa S. Oxidative stress and septic shock: metabolic aspects of oxygen-derived free radicals generated in the liver during endotoxemia. FEMS Immunol. Med. Microbiol. (2006) 47 167 177. (Pubitemid 43881736)
14. Meeus M., Nijs J. Central sensitization: a biopsychosocial explanation for chronic widespread pain in patients with fibromyalgia and chronic fatigue syndrome. Clin. Rheumatol. (2007) 26 465 473. (Pubitemid 46359284)
15. Yokoyama T., Lisi T.L., Moore S.A., Sluka K.A. Muscle fatigue increases the probability of developing hyperalgesia in mice. J. Pain. (2007) 8 692 699. (Pubitemid 47362839)
16. Watkins L.R., Wiertelak E.P., Goehler L.E. et al. Neurocircuitry of illness-induced hyperalgesia. Brain Res. (1994) 639 283 299. (Pubitemid 24078567)
17. Chen R., Moriya J., Yamakawa J.I. et al. Brain atrophy in a murine model of chronic fatigue syndrome and beneficial effect of Hochu-ekki-to (TJ-41). Neurochem. Res. (2008) 33 1365 1372.
18. Sharma S., Chopra K., Kulkarni S.K., Agrewala J.N. Resveratrol and curcumin suppress immune response through CD28/CTLA-4 and CD80 co-stimulatory pathway. Clin. Exp. Immunol. (2007) 147 155 163. (Pubitemid 44915567)
19. Tirkey N., Kaur G., Vij G., Chopra K. Curcumin, a diferuloylmethane, attenuates cyclosporine-induced renal dysfunction and oxidative stress in rat kidneys. BMC Pharmacol. (2005) 5 15.
20. Gupta A., Vij G., Sharma S. et al. Polyphenolic antioxidant, attenuates chronic fatigue syndrome in murine water immersion stress model. Immunobiology (2008) 214 33 39.
21. Kaur S., Anurag A., Tirkey N., Chopra K. Reversal of LPS-induced central and peripheral hyperalgesia by green tea extract. Phytother. Res. (2005) 19 39 43. (Pubitemid 40444992)
22. Wills E.D. Mechanisms of lipid peroxide formation in animal tissues. Biochem. J. (1966) 99 667 676.
23. Ellman G.L. Tissue sulfhydryl groups. Arch. Biochem. Biophys. (1959) 82 70 77.
24. Behan P.O., Behan W.M. Postviral fatigue syndrome. Crit. Rev. Neurobiol. (1988) 4 157 178. (Pubitemid 19018603)
25. Demitrack M.A., Dale J.K., Straus S.E. et al. Evidence for impaired activation of the hypothalamic-pituitary-adrenal axis in patients with chronic fatigue syndrome. J. Clin. Endocrinol. Metab. (1991) 73 1224 1234. (Pubitemid 121000696)
26. Elenkov I.J., Wilder R.L., Chrousos G.P., Vizi E.S. The sympathetic nerve - an integrative interface between two supersystems: the brain and the immune system. Pharmacol. Rev. (2000) 52 595 638.
27. Houtveen J.H., Kavelaars A., Heijnen C.J., vanDoornen L.J. Heterogeneous medically unexplained symptoms and immune function. Brain Behav. Immun. (2007) 21 1075 1082. (Pubitemid 47484391)
28. Buchwald D., Wener M.H., Pearlman T., Kith P. Markers of inflammation and immune activation in chronic fatigue and chronic fatigue syndrome. J. Rheumatol. (1997) 24 372 376. (Pubitemid 27104105)
29. Quan N., Herkenham M. Connecting cytokines and brain: a review of current issues. Histol. Histopathol. (2002) 17 273 288. (Pubitemid 34116430)
30. Quan N., Stern E.L., Whiteside M.B., Herkenham M. Induction of pro-inflammatory cytokine mRNAs in the brain after peripheral injection of subseptic doses of lipopolysaccharide in the rat. J. Neuroimmunol. (1999) 93 72 80. (Pubitemid 29051552)
31. Singh A., Naidu P.S., Gupta S., Kulkarni S.K. Effect of natural and synthetic antioxidants in a mouse model of chronic fatigue syndrome. J. Med. Food. (2002) 5 211 220. (Pubitemid 36331634)
32. Manuel y Keenoy B., Moorkens G., Vertommen J., De Leeuw I. Antioxidant status and lipoprotein peroxidation in chronic fatigue syndrome. Life Sci. (2001) 68 2037 2049. (Pubitemid 32245604)
33. McKenna M.J., Medved I., Goodman C.A. et al. N-acetylcysteine attenuates the decline in muscle Na+,K+-pump activity and delays fatigue during prolonged exercise in humans. J. Physiol. (2006) 576 279 288. (Pubitemid 44426236)
34. Lloyd A.R., Wakefield D., Boughton C.R., Dwyer J.M. Immunological abnormalities in the chronic fatigue syndrome. Med. J. Aust. (1989) 151 122 124. (Pubitemid 19193787)
35. MacDonald K.L., Osterholm M.T., LeDell K.H. et al. A case-control study to assess possible triggers and cofactors in chronic fatigue syndrome. Am. J. Med. (1996) 100 548 554. (Pubitemid 26170479)
36. Singal A., Kaur S., Tirkey N., Chopra K. Green tea extract and catechin ameliorate chronic fatigue-induced oxidative stress in mice. J. Med. Food. (2005) 8 47 52. (Pubitemid 40617037)
37. Logan A.C., Wong C. Chronic fatigue syndrome: oxidative stress and dietary modifications. Altern. Med. Rev. (2001) 6 450 459. (Pubitemid 33041792)
38. Dantzer R. How do cytokines say hello to the brain? Neural versus humoral mediation Eur. Cytokine Netw. (1994) 5 271 273. (Pubitemid 24212012)
39. Gaab J., Rohleder N., Heitz V. et al. Stress-induced changes in LPS-induced pro-inflammatory cytokine production in chronic fatigue syndrome. Psychoneuroendocrinology (2005) 30 188 198. (Pubitemid 39313115)
40. Maes M., Mihaylova I., Bosmans E. Not in the mind of neurasthenic lazybones but in the cell nucleus: patients with chronic fatigue syndrome have increased production of nuclear factor kappa beta. Neuro. Endocrinol. Lett. (2007) 28 456 462. (Pubitemid 47577726)
41. Maes M., Mihaylova I., Kubera M., Bosmans E. Not in the mind but in the cell: increased production of cyclo-oxygenase-2 and inducible NO synthase in chronic fatigue syndrome. Neuro. Endocrinol. Lett. (2007) 28 463 469. (Pubitemid 47577727)
42. Baeuerle P.A., Henkel T. Function and activation of NF-kappa B in the immune system. Annu. Rev. Immunol. (1994) 12 141 179.
43. Jagetia G.C., Reddy T.K., Venkatesha V.A., Kedlaya R. Influence of naringin on ferric iron induced oxidative damage in vitro. Clin. Chim. Acta. (2004) 347 189 197. (Pubitemid 39099622)
44. Punithavathi V.R., Anuthama R., Prince P.S. Combined treatment with naringin and vitamin C ameliorates streptozotocin-induced diabetes in male Wistar rats. J. Appl. Toxicol. (2008) 28 806 813.
45. Jung G., Hennings G., Pfeifer M., Bessler W.G. Interaction of metal-complexing compounds with lymphocytes and lymphoid cell lines. Mol. Pharmacol. (1983) 23 698 702.
46. Chen Y.T., Zheng R.L., Jia Z.J., Ju Y. Flavonoids as superoxide scavengers and antioxidants. Free Radic. Biol. Med. (1990) 9 19 21. (Pubitemid 120036876)
47. Singh D., Chopra K. The effect of naringin, a bioflavonoid on ischemia-reperfusion induced renal injury in rats. Pharmacol. Res. (2004) 50 187 193. (Pubitemid 38737251)
48. Kanno S., Shouji A., Asou K., Ishikawa M. Effects of naringin on hydrogen peroxide-induced cytotoxicity and apoptosis in P388 cells. J. Pharmacol. Sci. (2003) 92 166 170. (Pubitemid 36833465)
49. Jeon S.M., Bok S.H., Jang M.K. et al. Antioxidative activity of naringin and lovastatin in high cholesterol-fed rabbits. Life Sci. (2001) 69 2855 2866.
50. Singh D., Chander V., Chopra K. Protective effect of naringin, a bioflavonoid on glycerol-induced acute renal failure in rat kidney. Toxicology (2004) 201 143 151. (Pubitemid 39023942)
51. Rahman I., Gilmour P.S., Jimenez L.A., MacNee W. Oxidative stress and TNF-alpha induce histone acetylation and NF-kappaB/AP-1 activation in alveolar epithelial cells: potential mechanism in gene transcription in lung inflammation. Mol. Cell. Biochem. (2002) 235 239 248. (Pubitemid 34777863)
52. Cunningham C., Wilcockson D.C., Campion S., Lunnon K., Perry V.H. Central and systemic endotoxin challenges exacerbate the local inflammatory response and increase neuronal death during chronic neurodegeneration. J. Neurosci. (2005) 25 9275 9284. (Pubitemid 41500836)
53. Vanamala J., Leonardi T., Patil B.S. et al. Suppression of colon carcinogenesis by bioactive compounds in grapefruit. Carcinogenesis (2006) 27 1257 1265. (Pubitemid 43994864)
54. Tsai S.H., Lin-Shiau S.Y., Lin J.K. Suppression of nitric oxide synthase and the down-regulation of the activation of NFkappaB in macrophages by resveratrol. Br. J. Pharmacol. (1999) 126 673 680.
55. Kumazawa Y., Kawaguchi K., Takimoto H. Immunomodulating effects of flavonoids on acute and chronic inflammatory responses caused by tumor necrosis factor alpha. Curr. Pharm. Des. (2006) 12 4271 4279. (Pubitemid 44669755)